Who are Durintechnologies's investors?

Durintechnologies's investors include Foundation Venture Capital Group, LLC.

How much funding has Durintechnologies raised?

Durintechnologies has disclosed $15.2M raised across 3 rounds.

Where is Durintechnologies headquartered?

Durintechnologies is headquartered in Stratford, US.

Durintechnologies

Stratford, US · 1 known investors

Find your way into Durintechnologies

Paths you didn't know you had: your email and LinkedIn already hold routes to the Durintechnologies team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease. The diagnostic tests run in a CLIA-certified, CAP-accredited laboratory and target early detection, subtyping, and staging of neurodegenerative diseases.

AI & Machine Learning Biotech Digital Health

Founders & leadership

Mert SahinExecutive

Benjamin A. Belinka, Jr.Named on SEC filing

Board

Robert NageleBoard director

Rene ChazeBoard director

Investors · 1

Foundation Venture Capital Group, LLClisted by Foundation Venture Capital Group, LLCPrinceton · $500K

How we know: Foundation Venture Capital Group, LLC's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$15.2M disclosed across 3 rounds · 2019–2023

▶$6.2MraisedJul 2025 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Maribeth BluyusExecutive Officer
Robert NageleDirector
Rene ChazeDirector

Offering amount: $10M
Amount sold: $6.2M
First sale: Oct 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.5MraisedMar 2025 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Robert NageleDirector
Rene ChazeDirector
Mert SahinExecutive Officer

Offering amount: $5.5M
Amount sold: $5.5M
First sale: Mar 2021
Incorporated: Corporation, New Jersey
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$3.5MraisedDec 2019 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Rene ChazeDirector
Robert NageleDirector
Benjamin A. Belinka, Jr.Executive Officer

Offering amount: $3.5M
Amount sold: $3.5M
First sale: Nov 2019
Incorporated: Corporation, New Jersey
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Durintechnologies do?: Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease. The diagnostic tests run in a CLIA-certified, CAP-accredited laboratory and target early detection, subtyping, and staging of neurodegenerative diseases.
Who are Durintechnologies's investors?: Durintechnologies's investors include Foundation Venture Capital Group, LLC.
How much funding has Durintechnologies raised?: Durintechnologies has disclosed $15.2M raised across 3 rounds.
Where is Durintechnologies headquartered?: Durintechnologies is headquartered in Stratford, US.